Ling Y - Search Results

1

The effect of liver metastasis on efficacy of immunotherapy plus chemotherapy in advanced lung cancer.

Qin BD, Jiao XD, Liu J, Liu K, He X, Wu Y, Ling Y, Duan XP, Qin WX, Wang Z, Zang YS. Qin BD, et al. Among authors: ling y. Crit Rev Oncol Hematol. 2020 Mar;147:102893. doi: 10.1016/j.critrevonc.2020.102893. Epub 2020 Jan 30. Crit Rev Oncol Hematol. 2020. PMID: 32065969 Review.

2

Metastatic Low-Grade Sarcoma with CARS-ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis.

Jiao XD, Liu K, Xu M, Yu G, Liu D, Huang T, Qin BD, Liu M, Wu Y, Ling Y, Liu J, He X, Wang L, Li Y, Chen S, Zang YS. Jiao XD, et al. Among authors: ling y. Oncologist. 2021 Apr;26(4):e524-e529. doi: 10.1002/onco.13543. Epub 2020 Oct 16. Oncologist. 2021. PMID: 32997436 Free PMC article.

3

HER2 Splice Site Mutation c.1899-1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2-Positive Gastric Adenocarcinoma.

Jiao XD, Liu K, Wu Y, Zhou XC, Qin BD, Ling Y, Liu J, He X, Du H, Xiang J, Zang YS. Jiao XD, et al. Among authors: ling y. Oncologist. 2021 Sep;26(9):717-721. doi: 10.1002/onco.13799. Epub 2021 May 20. Oncologist. 2021. PMID: 33896090 Free PMC article.

4

Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report.

He X, Jiao XD, Liu K, Qin BD, Wu Y, Ling Y, Liu J, Xu AQ, Song K, Zang YS. He X, et al. Among authors: ling y. JCO Precis Oncol. 2021 May 3;5:PO.20.00534. doi: 10.1200/PO.20.00534. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34036227 Free PMC article. No abstract available.

5

Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer.

Qin BD, Jiao XD, Zhou XC, Shi B, Wang J, Liu K, Wu Y, Ling Y, Zang YS. Qin BD, et al. Among authors: ling y. Oncoimmunology. 2021 Jul 21;10(1):1929727. doi: 10.1080/2162402X.2021.1929727. eCollection 2021. Oncoimmunology. 2021. PMID: 34350061 Free PMC article.

6

Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma.

Jiao XD, Ding LR, Zhang CT, Qin BD, Liu K, Jiang LP, Wang X, Lv LT, Ding H, Li DM, Yang H, Chen XQ, Zhu WY, Wu Y, Ling Y, He X, Liu J, Shao L, Wang HZ, Chen Y, Zheng JJ, Inui N, Zang YS. Jiao XD, et al. Among authors: ling y. Transl Lung Cancer Res. 2021 Jul;10(7):3236-3250. doi: 10.21037/tlcr-21-543. Transl Lung Cancer Res. 2021. PMID: 34430361 Free PMC article.

7

Effect of smoking habits on the efficacy of EGFR-TKI plus anti-angiogenic agent in advanced EGFR-mutant NSCLC.

Qin BD, Jiao XD, Wang Y, Wu Y, Ling Y, Liu K, Zang YS. Qin BD, et al. Among authors: ling y. Lung Cancer. 2022 Aug;170:91-97. doi: 10.1016/j.lungcan.2022.06.006. Epub 2022 Jun 11. Lung Cancer. 2022. PMID: 35728482

8

Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy.

Duan XP, Liu K, Jiao XD, Qin BD, Li B, He X, Ling Y, Wu Y, Chen SQ, Zang YS. Duan XP, et al. Among authors: ling y. Front Oncol. 2023 Jan 4;12:1007146. doi: 10.3389/fonc.2022.1007146. eCollection 2022. Front Oncol. 2023. PMID: 36686739 Free PMC article.

9

Acquired EML4-ALK fusion and EGFR C797S in cis mutation as resistance mechanisms to osimertinib in a non-small cell lung cancer patient with EGFR L858R/T790M.

Wang LS, Chen SQ, Zhong X, Jiao XD, Liu K, Qin BD, Wu Y, Ling Y, Duan XP, Zang YS. Wang LS, et al. Among authors: ling y. Anticancer Drugs. 2023 Nov 1;34(10):1146-1150. doi: 10.1097/CAD.0000000000001489. Epub 2022 Dec 23. Anticancer Drugs. 2023. PMID: 36728908

10

Pan-cancer efficacy and safety of anlotinib plus PD-1 inhibitor in refractory solid tumor: A single-arm, open-label, phase II trial.

Qin BD, Jiao XD, Wang Z, Liu K, Wu Y, Ling Y, Chen SQ, Zhong X, Duan XP, Qin WX, Xue L, Guo ZH, Zang YS. Qin BD, et al. Among authors: ling y. Int J Cancer. 2023 Aug 15;153(4):815-825. doi: 10.1002/ijc.34546. Epub 2023 May 8. Int J Cancer. 2023. PMID: 37155342 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,133 results

Search Page